Endothelial dysfunction in atherosclerotic cardiovascular diseases and beyond: from mechanism to pharmacotherapies

S Xu, I Ilyas, PJ Little, H Li, D Kamato, X Zheng… - Pharmacological …, 2021 - ASPET
The endothelium, a cellular monolayer lining the blood vessel wall, plays a critical role in
maintaining multiorgan health and homeostasis. Endothelial functions in health include …

Therapeutic potential of colchicine in cardiovascular medicine: a pharmacological review

FS Zhang, QZ He, CH Qin, PJ Little, JP Weng… - Acta Pharmacologica …, 2022 - nature.com
Colchicine is an ancient herbal drug derived from Colchicum autumnale. It was first used to
treat familial Mediterranean fever and gout. Based on its unique efficacy as an anti …

Versican—a critical extracellular matrix regulator of immunity and inflammation

TN Wight, I Kang, SP Evanko, IA Harten… - Frontiers in …, 2020 - frontiersin.org
The extracellular matrix (ECM) proteoglycan, versican increases along with other ECM
versican binding molecules such as hyaluronan, tumor necrosis factor stimulated gene-6 …

[HTML][HTML] PARPs in lipid metabolism and related diseases

M Szántó, R Gupte, WL Kraus, P Pacher… - Progress in Lipid Research, 2021 - Elsevier
PARPs and tankyrases (TNKS) represent a family of 17 proteins. PARPs and tankyrases
were originally identified as DNA repair factors, nevertheless, recent advances have shed …

DAMPening inflammation by modulating TLR signalling

AM Piccinini, KS Midwood - Mediators of inflammation, 2010 - Wiley Online Library
Damage‐associated molecular patterns (DAMPs) include endogenous intracellular
molecules released by activated or necrotic cells and extracellular matrix (ECM) molecules …

Metformin, macrophage dysfunction and atherosclerosis

X Feng, W Chen, X Ni, PJ Little, S Xu, L Tang… - Frontiers in …, 2021 - frontiersin.org
Metformin is one of the most widely prescribed hypoglycemic drugs and has the potential to
treat many diseases. More and more evidence shows that metformin can regulate the …

Cardiovascular actions and therapeutic potential of tanshinone IIA

S Gao, Z Liu, H Li, PJ Little, P Liu, S Xu - Atherosclerosis, 2012 - Elsevier
Tanshinone IIA (TS), a pharmacologically active component isolated from the rhizome of the
Chinese herb Salvia miltiorrhiza Bunge (Danshen), has been clinically used in Asian …

LOX-1 in atherosclerosis: biological functions and pharmacological modifiers

S Xu, S Ogura, J Chen, PJ Little, J Moss… - Cellular and Molecular Life …, 2013 - Springer
Lectin-like oxidized LDL (oxLDL) receptor-1 (LOX-1, also known as OLR-1), is a class E
scavenger receptor that mediates the uptake of oxLDL by vascular cells. LOX-1 is involved …

Biological interplay between proteoglycans and their innate immune receptors in inflammation

H Frey, N Schroeder, T Manon‐Jensen… - The FEBS …, 2013 - Wiley Online Library
An emerging body of evidence indicates that secreted proteoglycans act as signaling
molecules, in addition to their canonical function in maintaining and regulating the …

Targeting epigenetics and non-coding RNAs in atherosclerosis: from mechanisms to therapeutics

S Xu, D Kamato, PJ Little, S Nakagawa… - Pharmacology & …, 2019 - Elsevier
Atherosclerosis, the principal cause of cardiovascular death worldwide, is a pathological
disease characterized by fibro-proliferation, chronic inflammation, lipid accumulation, and …